CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs)

by Nontaphat Thongsin, Methichit Wattanapanitch
Published 2022

A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity

by Nontaphat Thongsin, Methichit Wattanapanitch
Published 2022

Generation of B2M bi-allelic knockout human induced pluripotent stem cells (MUSIi001-A-1) using a CRISPR/Cas9 system

by Nontaphat Thongsin, Methichit Wattanapanitch
Published 2022

CRISPR/Cas9-Mediated GFP Reporter Knock-in in K562 and Raji Cell Lines for Tracking Immune Cell Killing Assay

by Nontaphat Thongsin, Methichit Wattanapanitch
Published 2022

A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors

by Koollawat Chupradit, Nontaphat Thongsin, Chatchai Tayapiwatana, Methichit Wattanapanitch
Published 2022

Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors

by Nunghathai Sawasdee, Methichit Wattanapanitch, Nontaphat Thongsin, Nattaporn Phanthaphol, Chutipa Chiawpanit, Chanitra Thuwajit, Pa Thai Yenchitsomanus, Aussara Panya
Published 2022

Generation of an induced pluripotent stem cell line (MUSIi014-A) from an affected member of a family with autosomal dominant diabetes carrying p.L475P mutation in ZYG11A gene assoc...

by Chutima Chanprasert, Nutchanawan Promnakhon, Nontaphat Thongsin, Siriwal Suwanpitak, Nattachet Plengvidhya, Pa thai Yenchitsommanus, Prapaporn Jungtrakoon Thamtarana, Methichit Wattanapanitch
Published 2022